Source: International Congress 2017 – Rare diseases
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Kawamatawong (Bangkok, Thailand). Clinical and radiological correlation of pulmonary complications in CHOP versus rituximab-CHOP regimen treated non-Hodgkin’s lymphoma in Thailand. 3860

Member's Comments

No comment yet.

Related content which might interest you: Primary pulmonary non-Hodgkin's lymphoma [NHL] and advanced NHL with pulmonary involvement -rare entity and difficult diagnosis Source: Eur Respir J 2002; 20: Suppl. 38, 467s Year: 2002 Granulomatous lung disease in lymphoma patient after rituximab treatment Source: Virtual Congress 2020 – Interstitial lung diseases Year: 2020 Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Clinical characteristics and follow-up of pulmonary MALT lymphoma Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Pulmonary tuberculosis in hodgkin's disease after high dose chemotherapy Source: Annual Congress 2003 - Clinical aspects of tuberculosis Year: 2003 Pulmonary function changes after chemotherapy and radiotherapy for Lymphoma. Source: International Congress 2017 – Case reports and series Year: 2017 Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients Source: Eur Respir Rev 2013; 22: 93-95 Year: 2013 Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Pulmonary toxicity of treatments for leukaemia and lymphoma Source: International Congress 2018 – Respiratory medicine meets hematology Year: 2018 Endobronchial primary pulmonary non-Hodgkin lymphoma development in a patient with rheumatoid arthritis Source: Eur Respir J 2001; 18: Suppl. 33, 398s Year: 2001 Thoracic manifestations of Hodgkin lymphoma Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology Year: 2007 Efficacy of a standard chemotherapy regimen in the management of sputum-positive pulmonary TB relapses Source: Eur Respir J 2003; 22: Suppl. 45, 41s Year: 2003 Pulmonary non-Hodgkin‘s lymphoma developed during long-term methotrexate therapy for rheumatoid arthritis Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Comparison of treatment of TB lymphadenitis with daily vs. intermittent chemotherapy Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis Year: 2011 Predictive role of MMP-2 genetic variants on severe hematologic toxicity of NSCLC patients treated with first-line, platinum-based chemotherapy Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011 Medical tumors of the sternum: solitary plasmocytoma and Hodgkin lymphoma – surgical management Source: Eur Respir J 2006; 28: Suppl. 50, 91s Year: 2006 Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014 First ever report of histologically proven bronchiolitis obliterans organizing pneumonia after antineoplastic treatment of a malignant pleural mesothelioma with cisplatin and pemetrexed Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases Year: 2011